Navigation Links
Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression
Date:3/31/2011

ROCKVILLE, Md., March 31, 2011 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced its plans to initiate a Phase IIb/III clinical trial of tasimelteon in patients with Major Depressive Disorder (MDD).  The trial is expected to begin during the second half of 2011.  Tasimelteon is currently being evaluated in Phase III clinical trials for the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals without light perception.

"Research suggests that misalignment of the circadian rhythm, or body clock, may have significant health consequences, including those related to mood disorders such as major depression," said Mihael H. Polymeropoulos, M.D., Vanda's President and CEO.  "Treating depression with a circadian regulator is a novel concept, which has more recently become an area of focus for the pharmaceutical industry. Expansion of our investigations into MDD is consistent with our vision for Vanda as a leading specialty pharmaceutical company focused on the development and commercialization  of differentiated products for central nervous system disorders."

There is considerable evidence that suggests circadian rhythm disturbances are important in the pathophysiology of mood disorders. Depressed patients often show altered circadian rhythms, sleep disturbances, and diurnal mood variation. Chronotherapies, including bright light exposure, have been successfully used to treat seasonal and non-seasonal mood disorders. These observations suggest that aberrations of the circadian clock may significantly contribute to the production of the symptoms of MDD and therefore treatments that aim at restoring the regulation of the circadian clock could prove beneficial (1).

Despite the availability of a number of treatments for MDD, there remains a significant unmet medical need.  In the large Star*D study spon
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Research and Markets ( http://www.researchandmarkets.com/research/64lx2w/north_america_mri ) has announced the ... Growth, Trends And Forecasts (2014 - 2019)" report ... systems market is estimated to increase from the current ... with a CAGR of 2.9% between 2014 and 2020. ... system, closed system and the standing or upright system. ...
(Date:5/29/2015)... Tenn. , May 29, 2015  Dr. Yair ... practice to resolve vaginal health issues often caused by menopause. ... and requires no anesthesia, received FDA clearance in 2014. Dr. ... Tennessee to offer the special fractional CO 2 ... as breast cancer survivors. In 2010 there ...
(Date:5/29/2015)... LifeNet Health plans to enlarge its workforce ... more than 160 people. The organization,s growth ... innovative bio-implants, which are being made more widely available ... It also is a reflection of the region,s growing ... and success of LifeNet Health is a great example ...
Breaking Medicine Technology:North America MRI Market - Growth, Trends And Forecasts 2014-2019 with GE, Hitachi Medical, Philips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2LifeNet Health to add more than 160 jobs in 2015 2
... Identifying successful strategies for specialty pharmacy benefit programs ... Therapeutics Vice President of Specialty Pharmacy Solutions Elizabeth ... Senior Director of Clinical Pharmacy Programs Beckie Fenrick ... 6th Annual Executive Forum on Pharmacy Benefit Management ...
... ,   Shire plc ... specialty,biopharmaceutical company, today announced that the European,Medicines Agency has ... substance at its new,manufacturing facility in Lexington, MA, US. ... is the first product that will be made available ...
Cached Medicine Technology:Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies 2European Authorities Approve New Manufacturing Facility for Shire's REPLAGAL® (agalsidase alfa) 2European Authorities Approve New Manufacturing Facility for Shire's REPLAGAL® (agalsidase alfa) 3
(Date:5/30/2015)... May 30, 2015 The Brain Fitness ... coordination with ONEgeneration Senior Enrichment Center, headed by 1Heart ... de Guzman and Brain Fitness Program Director Tee Barr. ... event learned that there are many ways to enrich ... showed the residents the different ways to overcome dementia ...
(Date:5/30/2015)... 2015 Wixom, Michigan: Proof. Pest Control, a family-owned ... a new twist to its robust line of services-a ... used for general pest management. , “We like ... Wixom Branch Manager. “The average person cringes when they see ... with problems that most people don’t even want to think ...
(Date:5/30/2015)... Key Housing, a top-rated corporate housing ... their June 2015 featured apartment community: 388 Beale Street. ... Key Housing is helping those people looking for corporate ... of the tightest apartment markets in the United States. ... anyone who requires temporary San Francisco corporate housing is ...
(Date:5/30/2015)... FL (PRWEB) May 30, 2015 This ... partners with Pulmonary Horizons to offer one of ... effectively identify and discuss successful practices to diagnose, treat ... Attending the Pulmonary Horizons Conference is Interaction ... can address the Overall Needs of Patients with COPD," ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 A live ... of medical equipment from hospitals, surgery centers and other ... equipment will be sold including radiology, surgery, endoscopy, lab, ... auction will take place Tuesday, June 2nd starting at ... warehouse located at 5025 North Hiatus Rd., Sunrise, FL ...
Breaking Medicine News(10 mins):Health News:1Heart Caregiver Services Brings Brain Fitness Education Seminar at ONEgeneration 2Health News:1Heart Caregiver Services Brings Brain Fitness Education Seminar at ONEgeneration 3Health News:Proof. Pest Control-Now Offering 100% Organic Pest Control in Southeast Michigan 2Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 2Health News:San Francisco Corporate Housing Leader Key Housing Designates 388 Beale Street as Featured Community for June 3Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 3Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2
... Symmetry Medical Inc.,(NYSE: SMA ), a leading independent ... other medical markets, announced today that,it will release first ... before the market opens on Tuesday, June 24, 2008. ... a.m. ET on,Tuesday, June 24., A live Web ...
... in Ireland will,soon be able to take advantage ... (NYSE: DGX ), the world,s leader in,cervical-cancer ... Cancer Screening Service (NCSS), Quest Diagnostics will provide,quality-assured ... anxiety wait time for women ages 25 to ...
... Provides Update on AMEX Appeal Hearing, TORONTO, ... (TSX: PMD; Amex: PME) today announced the successful ... health and beauty companies.,As a result of the ... into,additional agreements with the company for further product ...
... Automated Systems Issuing Credit without Verification Put Millions at ... companies are,knowingly contributing to the identity theft epidemic by ... to apply for and receive credit using,stolen information. Hospital ... a stolen social security number are able to manipulate,the ...
... Given Green Light by Insurers, SANTA MONICA, ... California health regulators acknowledged that patients,should be able ... their health coverage. Yet the details of the ... insurers, said Consumer Watchdog,allowing them in many cases ...
... linked to pulmonary arterial hypertension, study found , , ... bosentan reduced clinical decline in patients with early-stage ... PAH is a progressive disease in which increased ... to the heart, eventually leading to heart failure ...
Cached Medicine News:Health News:Symmetry Medical to Report First Quarter 2008 Financial Results on June 24, 2008 2Health News:Quest Diagnostics to Provide Diagnostic Testing Services for the Women of Ireland through Ireland's First Nationwide Cervical-Cancer Screening Program 2Health News:Quest Diagnostics to Provide Diagnostic Testing Services for the Women of Ireland through Ireland's First Nationwide Cervical-Cancer Screening Program 3Health News:Quest Diagnostics to Provide Diagnostic Testing Services for the Women of Ireland through Ireland's First Nationwide Cervical-Cancer Screening Program 4Health News:PreMD Successfully Completes Project for Health & Beauty Company 2Health News:Credit Card Companies Fueling Healthcare Associated Identity Theft (HAIT) Crimes 2Health News:PacifiCare 'Rescission' Settlement Gives Lip Service to Patient Losses But Stacks Legal Deck in Favor of Insurers 2Health News:Drug Effective Against Heart-Lung Disorder 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: